Not yet recruiting
HIV infection
Not yet recruitingSafety and Efficacy of Dasatinib in Reducing HIV-1 Reservoir, Inflammation, and Immune Senescence in People with HIV on Long‑Term Antiretroviral Therapy
Registered drug
Safety and Efficacy of Dasatinib in Reducing HIV-1 Reservoir, Inflammation, and Immune Senescence in People with HIV on Long‑Term Antiretroviral Therapy
Registered drug
- Disease:HIV infection
- Substances:Dasatinib
Countries:
Spain
Spain- Participants:18–64 years · 65+ years
- Substances:Dasatinib
- Sponsor:Instituto De Salud Carlos III
